{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:25:52Z","timestamp":1778221552914,"version":"3.51.4"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:p>This Viewpoint advocates for better research in treatments and clinical practice for brain metastasis stemming from lung cancer.<\/jats:p>","DOI":"10.1001\/jamaoncol.2023.2129","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:07:48Z","timestamp":1689260868000},"page":"1197","source":"Crossref","is-referenced-by-count":2,"title":["Patients With Brain Metastases Deserve Better\u2014A Hard-Won Perspective"],"prefix":"10.1001","volume":"9","author":[{"given":"Laura","family":"Greco","sequence":"first","affiliation":[{"name":"Lung Cancer Patient and Advocate"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"cpo230001r1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/nop\/npab042","article-title":"Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases.","volume":"8","author":"Kim","year":"2021","journal-title":"Neurooncol Pract"},{"issue":"10","key":"cpo230001r2","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jtho.2018.07.004","article-title":"Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET-rearranged lung cancers.","volume":"13","author":"Drilon","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"10","key":"cpo230001r3","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"cpo230001r4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtho.2022.09.219","article-title":"Factors associated with developing neurocognitive adverse events in patients receiving lorlatinib after progression on other targeted therapies.","volume":"18","author":"Dagogo-Jack","year":"2023","journal-title":"J Thorac Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2807032\/jamaoncology_greco_2023_po_230001_1695221894.55021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T18:02:06Z","timestamp":1695319326000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2807032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":4,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.2129","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}